All In Biotech

Drug Trial Radar · NCT05970432

A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial Evaluating the Efficacy and Safety of TQH2722 Injection in Subjects With Moderate to Severe Atopic Dermatitis

Last checked: Nov 20, 2026Latest source record: Aug 1, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

160

Planned (sponsor's estimate)

Start

Jun 19, 2023

Primary completion

Mar 2024

Study completion Mar 2024

Sponsor

Sponsor type
Industry
First posted
Aug 1, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II clinical trials is multicenter, randomized, double-blind, placebo-controlled to assess the effectiveness and safety of TQH2722 injection in the treatment of subjects with moderate to severe atopic dermatitis.

Conditions

  • Atopic Dermatitis

Interventions

  • TQH2722 injection 300mg-150mgDrug

    TQH2722 injection is a fully human monoclonal antibody that interfering with the signal cascade.

  • TQH2722 injection 600mg-300mgDrug

    TQH2722 injection is a fully human monoclonal antibody that thereby interfering with the signal cascade.

  • TQH2722 injection 900mg-450mgDrug

    TQH2722 injection is a fully human monoclonal antibody that thereby interfering with the signal cascade.

  • TQH2722 injection matching PlaceboDrug

    Placebo without active substance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Eczema area and severity (EASI)-75 (≥75% improvement from baseline).Time frame: Up to 16 weeks.

Locations

32 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Wannan Medical College

    Wuhu, Anhui, China · Recruiting

  • Dermatology Hospital, Southern Medical University

    Guangzhou, Guangdong, China · Recruiting

  • The Second Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China · Recruiting

  • Shenzhen People's Hospital

    Shenzhen, Guangdong, China · Recruiting

  • Affiliated Hospital of Guilin Medical University

    Guilin, Guangxi, China · Recruiting

  • Affiliated Hospital of Hebei Engineering University

    Handan, Hebei, China · Recruiting

  • The Forth Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Recruiting

  • The second affiliated hospital of harbin medical university

    Harbin, Heilongjiang, China · Recruiting

  • Puyang District Hospital of Anyang City

    Anyang, Henan, China · Recruiting

  • The First People's Hospital of Nanyang

    Nanyang, Henan, China · Recruiting

  • People's Hospital of Henan province

    Zhengzhou, Henan, China · Recruiting

  • Shiyan Renmin Hospital

    Shiyan, Hubei, China · Recruiting

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China · Recruiting

  • The third xiangya hospital of central south university

    Changsha, Hunan, China · Recruiting

  • Qian-jin Lu

    Nanjing, Jiangsu, China · Recruiting

  • Affiliated Hospital of Jiujiang University

    Jiujiang, Jiangxi, China · Recruiting

  • The Second Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • Panjin Liaoyou Gem Flower Hospital

    Panjin, Liaoning, China · Recruiting

  • The First Affiliated Hospital of China Medical University

    Shenyang, Liaoning, China · Recruiting

  • Air Force Medical University

    Xi'an, Shaanxi, China · Recruiting

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, China · Recruiting

  • Shengli Oil Field Central Hospital

    Dongying, Shandong, China · Recruiting

  • Shandong First Medical University Affiliated Dermatology Hospital

    Jinan, Shandong, China · Recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Recruiting

  • The Affiliated Hospital Of Qingdao University

    Qingdao, Shandong, China · Recruiting

  • Huashan Hospital Affiliated to Fudan University

    Shanghai, Shanghai Municipality, China · Recruiting

  • Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • Xinjiang Uygur Autonomous Region People's Hospital

    Ürümqi, Xinjiang Uygur Autonomous Region, China · Recruiting

  • The First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China · Recruiting

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

  • The First People's Hospital of Wenling

    Wenling, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.